The best-supported natural treatment for oppositional defiant disorder (ODD) is parent management training, a drug-free approach that changes how adults respond to a child’s behavior. No supplement has been shown to treat ODD itself. Omega-3s and vitamin-mineral formulas have small, mixed results, mostly in studies of ADHD or general samples rather than ODD, and the elimination-diet research comes from ADHD studies.
ODD is a problem of regulation that shows up inside relationships, and the diagnosis is written that way: its symptoms are defined largely by how a child behaves toward authority figures such as parents and teachers. The treatments with the strongest evidence change the pattern between a child and the adults around them. Nutrition research deserves the same lens, because in many of these trials a parent is the main rater, and a parent who expects change behaves differently.
What ODD is, and what it is not
In the current diagnostic manual, ODD is a pattern of angry or irritable mood, argumentative or defiant behavior, or vindictiveness lasting at least six months. A child needs at least four of eight listed symptoms, and they must show up with at least one person who is not a sibling.1,2 Because all children argue, there is a frequency floor: most days for children under five, at least weekly from age five, and at least twice in six months for vindictiveness. Severity is graded by how many settings the symptoms appear in, from mild (one setting) to severe (three or more).2 In preschoolers ODD is hard to tell from ordinary defiance, though a stable oppositional pattern at that age often persists into grade school.3
A worldwide meta-analysis of 41 community studies put the pooled prevalence of any disruptive disorder, the group that includes ODD and conduct disorder, at 5.7%.4 Children with ODD have high rates of ADHD and mood disorders, and their relationships with parents, teachers and peers are often substantially strained.3
Two findings complicate the usual picture. In UK national surveys of 18,415 young people aged 5 to 16, Argyris Stringaris and Robert Goodman split oppositional symptoms into irritable, headstrong and hurtful dimensions. Only irritability predicted emotional disorders; headstrong symptoms tracked with ADHD, and hurtful ones with callousness and aggression.5 The Great Smoky Mountains Study, which followed 1,420 young people between ages 9 and 21, then found that ODD predicted later conduct disorder in boys but not girls, that moves from ODD to conduct disorder were less common than expected, and that while conduct disorder mostly predicted later behavioral problems, ODD was the stronger predictor of emotional disorders in early adulthood.6 ODD is not simply a first step toward delinquency. For some children, especially those whose main symptom is irritability, it is closer to a mood problem expressed through conflict, and irritability is now recognized as a mood problem in its own right, the core feature of the newer diagnosis disruptive mood dysregulation disorder.7
A 2017 review cites a heritability estimate of 61% and a large genetic overlap with conduct disorder, but notes that no specific gene variant has been identified with confidence.2 Diagnosis also depends on who is judging. A 2020 commentary in Academic Psychiatry reviews evidence that, compared with non-Hispanic White youth, Black and Hispanic youth are more likely to receive a disruptive behavior diagnosis and less likely to receive an ADHD diagnosis, and raises concern that clinicians’ unconscious bias plays a part.8
Why defiance is a relationship problem first
The most useful model of how oppositional behavior grows comes from the psychologist Gerald Patterson, whose 1982 book Coercive Family Process described a loop that both people learn.9 A parent makes a request. The child protests, then escalates. If the parent gives in, the child learns that escalation works, and the parent learns that giving in ends the noise. If the parent escalates until the child complies, the parent learns that harshness works. Each side is rewarded for the move that makes the next round worse. It is ordinary learning, running in both directions.
Expectations feed the loop. In one experiment, Daniel Hoover and Richard Milich worked with 35 boys aged 5 to 7 whose mothers described them as sugar-sensitive. Every boy actually received a placebo, the sweetener aspartame, but some mothers were told their son had just had a large dose of sugar. Those mothers rated their sons as more hyperactive, and on video they exercised more control, staying physically closer, with trends toward more criticism. On several measures the effect was stronger in mothers who scored as more cognitively rigid.10 A parent’s belief changed the parent’s behavior, and the parent’s behavior is what the coercive loop runs on.
The relationship also predicts how treatment goes. In 134 children with ODD treated with one of two therapies, stronger parental monitoring before treatment predicted fewer behavior problems afterward, while family hostility and permissiveness predicted more. Parental warmth predicted the biggest gains in adaptive skills for families in parent management training.11
None of this means parents cause ODD. A child’s heritable traits can draw particular responses from the people around them, which then shape the child in turn.2 The loop is simply the part that can be changed without anyone being at fault, and changing it is the best-supported drug-free option we have.
The natural treatment with the strongest evidence
Parent management training (PMT) teaches caregivers specific, practiced skills: paying close attention to behavior they want more of, giving brief and clear instructions, letting minor provocations pass, and following through with calm, predictable consequences. A Cochrane review of 13 trials with 1,078 participants found that group-based behavioral parenting programs for children aged 3 to 12 reduced conduct problems, with a moderate effect by parent report (standardized mean difference −0.53) and a somewhat smaller but still significant effect by independent assessment (−0.44). Parents’ mental health improved and harsh parenting dropped.12
The newest pooled evidence agrees. A 2026 meta-analysis in Pediatrics combined 64 randomized trials published since 2014. Parent-only programs reduced disruptive behavior in preschoolers (standardized mean difference −0.61) and school-age children (−0.39), and programs that worked with a parent or teacher plus the child showed larger pooled effects (−0.96 and −0.61). Those results were parent-reported and measured right after treatment; longer-term results were less consistent, and adolescent trials could not be pooled.13
Which parts matter? Across 77 evaluations of programs for children up to age 7, effects were larger when programs built positive parent-child interaction and emotional communication, taught time-out and consistency, and had parents practice with their own child during sessions.14 A 2017 evidence update for children 12 and under rates group parent behavior therapy, and individual parent behavior therapy with the child taking part, as well-established, the highest category.15
The UK’s National Institute for Health and Care Excellence (NICE) recommends group parent training for parents of children aged 3 to 11 who have ODD or conduct disorder or are at high risk: typically 10 to 16 meetings, built on a social learning model and on a manual with positive randomized-trial evidence, with an individual program when a group is not possible.16 The American Academy of Child and Adolescent Psychiatry’s practice parameter calls for multimodal treatment that combines individual and family therapy, medication and sociotherapy, and notes that ODD’s controlled-trial base is thin.17
Parent training is not the only option. Psychologist Ross Greene’s model, Collaborative & Proactive Solutions (CPS), grew out of his 1998 book The Explosive Child.18 It treats chronic defiance as a sign of lagging skills in flexibility, adaptability and problem solving. Clinicians help parents list the unsolved problems that set off episodes, such as homework or chores, then teach them to solve those problems with the child rather than imposing a solution and a consequence.19 In a randomized trial of 134 children aged 7 to 14 with ODD, CPS and PMT worked equally well: about half the children in each treatment no longer met criteria and were rated much or very much improved, compared with none on the waitlist, and gains held at six months.19 A 2023 community trial in Australia with 160 children found the same equivalence.20 Greene co-authored both trials.
Both well-tested, drug-free routes work on the relationship. Our child and teen therapy page describes how we approach this work with families in Hoover.
Where medication fits
Medication is not a first-line treatment for ODD. NICE advises against medication for the routine management of behavior problems in ODD or conduct disorder, while recommending methylphenidate or atomoxetine for a child who also has ADHD.16 The strongest drug evidence is in children with both conditions. A 2015 meta-analysis rated as high quality the evidence that stimulants have a moderate-to-large effect on oppositional behavior, conduct problems and aggression in youth with ADHD, with or without ODD; guanfacine and atomoxetine had smaller effects.21 Our page on ADHD and AuDHD covers that overlap.
Antipsychotics are a different matter. A 2017 Cochrane review of 10 trials and 896 children found low- to moderate-quality evidence that risperidone reduced aggression and conduct problems in the short term, and that children on it gained about 2.4 kg more than those on placebo. None of the included trials tested aripiprazole. Given how well parent training works, the reviewers concluded that medication should not be used alone.22 A 2025 federal evidence review found only limited support for stimulants or antipsychotics in disruptive behavior; children on medication were more than three times as likely as those on placebo to quit trials because of side effects, though serious adverse events were rare.23 Risperidone and aripiprazole are FDA-approved for irritability associated with autism, but ODD is not an approved indication for either, so prescribing them for defiance is off-label. A 2025 review found that about two in three young people taking antipsychotics receive them off-label and called the practice an enduring public health concern.24,25 Any medication decision belongs with your child’s pediatrician or psychiatrist.
Supplements: what the pediatric trials show
Holding nutrition claims to pediatric standards means asking four questions. Was the study in children? Was there a placebo? Did the rater know who got what? Has anyone repeated it? Blinding matters most. When Edmund Sonuga-Barke and colleagues pooled randomized trials of non-drug ADHD treatments, every dietary and psychological treatment looked effective when rated by the people closest to the treatment setting. Under the best blinded rating available, most of those effects shrank to nonsignificance. Fatty acid supplements kept a small effect, and removing artificial food colors kept a larger one, often in children already selected for food sensitivity.26 The same test cuts both ways: behavioral treatments also failed it for core ADHD symptoms, which is why the independent-observer result for conduct problems in the Cochrane review above carries weight.12,26
Omega-3 fatty acids
Omega-3s have been tested against aggression often enough to support a meta-analysis. Across 40 intervention and observational studies with 7,173 participants, two-group comparisons showed a small effect (standardized mean difference 0.20), and the size depended on how aggression was measured.27 One pediatric trial, run by Adrian Raine’s group in Mauritius, randomized 200 community children aged 8 to 16 to an omega-3 fruit drink or the same drink without omega-3 for six months. Parent-reported behavior problems improved and stayed improved six months later. Children’s own reports did not change, except for aggression. The parents’ own antisocial and aggressive behavior also dropped, and that change partly explained the children’s improvement.28 Even in a supplement study, part of the change ran through the parent.
Trials in children with disruptive behavior are small. In a 2003 pilot with 50 children, a fatty acid supplement beat olive oil on only 2 of 16 outcomes, one of them parent-rated conduct problems.29 In 72 depressed children aged 7 to 14, the clearest behavioral gains came when omega-3s were combined with a family-focused therapy.30 These are reasons for more research, not proof of a treatment. The claim, from a post folded into this one, that research consistently shows low serotonin goes with aggression, so serotonin-supporting nutrients may reduce it, also overstates the evidence. A meta-analysis of 175 samples found only a small inverse correlation between serotonin function and aggression (r = −.12), and effect sizes shrank in later studies.31
Broad-spectrum vitamin-mineral formulas
Two blinded trials tested a broad-spectrum vitamin and mineral formula in children with ADHD. In New Zealand, 93 medication-free children aged 7 to 12 took it or a placebo for 10 weeks. Clinicians rated 47% on the formula as much or very much improved versus 28% on placebo. Overall ADHD symptom ratings did not differ, but clinicians, parents and teachers reported better emotional regulation and less aggression.32 The larger North American MADDY trial randomized 135 unmedicated children aged 6 to 12 with ADHD and irritability for 8 weeks. Blinded clinicians rated 54% on the formula as responders versus 18% on placebo. The parent-rated primary outcome, which combined ADHD, oppositional, mood-dysregulation and peer-conflict symptoms, improved in both groups with no difference between them. The authors suggest that parents giving capsules three times a day may simply have given more attention and praise.33
Both trials used Daily Essential Nutrients, donated by Hardy Nutritionals.32,33 We explain why some of our clinicians recommend Hardy Nutritionals in a separate article, and our micronutrition page describes how we use it. Taproot receives a small commission on Hardy sales made through our offer code, which is one more reason to read the trials yourself. The honest summary for ODD: blinded clinicians saw broad improvement in both trials, but in the larger one parent-rated oppositional symptoms did not separate from placebo, and neither trial selected children for ODD.
Older groups give mixed results. A vitamin, mineral and fatty acid supplement cut disciplinary offenses by about 26% among 231 British young adult prisoners.34 A Dutch replication with 221 prisoners found fewer staff-reported incidents but no change on other aggression measures.35 In 196 UK teenagers, teacher ratings of disruptive behavior improved, while school disciplinary infringements rose by about a quarter in both groups.36
Vitamin D, zinc, iron and magnesium
In a Finnish trial that gave infants a higher or standard daily dose of vitamin D through age two, the higher dose was linked to fewer internalizing problems at ages 6 to 8, with no difference in externalizing (behavioral) problems.37 A US pilot trial of zinc in 52 children with ADHD found equivocal clinical effects.38 Iron has a mixed association with ADHD symptoms; children with ADHD and sleep problems such as restless legs are at risk of deficiency, and low iron may blunt the response to stimulants.39 That argues for asking your pediatrician to check iron, not for giving it by guesswork. We found no controlled trial of magnesium in ODD. The closest is a single eight-week trial in Iran in which 66 children with ADHD took high-dose vitamin D plus magnesium or a placebo; parent ratings of conduct problems improved more on the supplements than on placebo.40 That is one small trial with parent-rated outcomes, in ADHD rather than ODD. Our article comparing magnesium L-threonate and glycinate covers what is known in adults. A real deficiency is a medical finding, and our piece on biological triggers that often go untested walks through how to raise that with a doctor.
Herbs, L-theanine and probiotics
Several of the earlier citations here did not hold up. The L-theanine trial in boys with ADHD measured sleep, not anxiety or attention: 98 boys aged 8 to 12 had better sleep efficiency on a wrist monitor after six weeks, and their parents’ sleep questionnaires did not match the objective data.41 The chamomile trial was real but involved 57 adults with generalized anxiety disorder, with a modest benefit.42 We found no controlled trial of chamomile, lemon balm or L-theanine in children with ODD, and the same holds for calming herbs marketed to adults, such as magnolia bark. The gut-brain studies often cited were in healthy adults: a probiotic reduced self-reported reactivity to sad mood, mostly rumination and aggressive thoughts, in 40 volunteers, and one of two prebiotics lowered the morning cortisol response in 45 volunteers.43,44 None tested a child’s behavior. Under the Dietary Supplement Health and Education Act of 1994, manufacturers, not the FDA, are responsible for evaluating a supplement’s safety and labeling before it is sold, and the FDA acts mainly after a product reaches the market.45 Talk with your child’s pediatrician or prescriber before starting any supplement, especially if your child takes medication.
Diet, sugar, sleep and movement
Sugar is the cleanest test of the expectancy problem. A meta-analysis of 23 double-blind studies found that sugar does not affect children’s behavior or cognition, and suggested that parents’ strong belief to the contrary comes from expectation and association, though it could not rule out a small effect or effects in some children.48
Sleep deserves at least as much attention as any supplement. The links between sleep problems and children’s emotional and behavioral difficulties appear to run in both directions, so poor sleep can feed irritability and defiance, and those difficulties can in turn disrupt sleep.49 Melatonin is widely used as a sleep aid for children, and it is not trivial: from 2012 to 2021, US poison centers recorded 260,435 melatonin ingestions by children and teens, and the yearly number rose 530%. Rising hospitalizations were driven mainly by unintentional ingestions in children five and under; five children needed mechanical ventilation and two died.50 Use it only with your pediatrician’s guidance and store it like medicine. Our article on natural remedies for insomnia covers behavioral sleep strategies. Exercise has modest support: a meta-analysis of 57 studies in adolescents found small-to-moderate effects of physical activity programs on externalizing problems (d = 0.32).51
What this looks like in therapy
Good treatment starts with assessment rather than a label. A clinician asks when the conflict happens, where, and with whom, because a child who is defiant only at homework time is telling you something different from a child who is irritable everywhere. The NICE guideline asks clinicians to check for coexisting mental health problems, ADHD, autism, learning difficulties and substance misuse.16 Sleep, family stress and the child’s physical health belong in the picture too, so the child’s pediatrician should be part of the conversation.
Much of the work happens with parents, often with the child in the room so new skills can be practiced and coached on the spot, a component tied to larger effects.14 Parents learn to catch and name the behavior they want, give one clear instruction instead of five, let small provocations pass, and follow through calmly. In a collaborative approach, the same sessions are used to list the problems that keep setting off episodes, pick one, and work it through with the child instead of deciding the answer in advance.19
We also pay attention to the adult’s nervous system. Parent training improves parents’ own mental health, and that is not a side effect.12 A standoff with a defiant child can pull a parent into their own history with authority, shame or helplessness; a parent who notices that pull can choose a different response. In somatic and parts-based work, we slow those moments down so the adult can stay steady while the child is not. When the whole household is caught in the pattern, family counseling gives everyone a place to work on it together.
If a family wants to try a supplement, we suggest treating it like an experiment. Make one change at a time, clear it with the prescriber, decide in advance what you will measure, and ask someone who does not know about the change, such as a teacher, how things are going. That is the closest a family can get to the blinded rating the research depends on.
If your family is stuck in the same fight every evening, that is a common and workable problem. Our child and teen therapists work with parents and children in Hoover, minutes from Birmingham, and you can contact us to ask whether we are a good fit.
References
- American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9780890425787
- Ghosh, A., Ray, A., & Basu, A. (2017). Oppositional defiant disorder: Current insight. Psychology Research and Behavior Management, 10, 353–367. https://doi.org/10.2147/PRBM.S120582
- Hamilton, S. S., & Armando, J. (2008). Oppositional defiant disorder. American Family Physician, 78(7), 861–866. PubMed ID 18841736. https://pubmed.ncbi.nlm.nih.gov/18841736/
- Polanczyk, G. V., Salum, G. A., Sugaya, L. S., Caye, A., & Rohde, L. A. (2015). Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. Journal of Child Psychology and Psychiatry, 56(3), 345–365. https://doi.org/10.1111/jcpp.12381
- Stringaris, A., & Goodman, R. (2009). Three dimensions of oppositionality in youth. Journal of Child Psychology and Psychiatry, 50(3), 216–223. https://doi.org/10.1111/j.1469-7610.2008.01989.x
- Rowe, R., Costello, E. J., Angold, A., Copeland, W. E., & Maughan, B. (2010). Developmental pathways in oppositional defiant disorder and conduct disorder. Journal of Abnormal Psychology, 119(4), 726–738. https://doi.org/10.1037/a0020798
- Stringaris, A., Vidal-Ribas, P., Brotman, M. A., & Leibenluft, E. (2018). Practitioner review: Definition, recognition, and treatment challenges of irritability in young people. Journal of Child Psychology and Psychiatry, 59(7), 721–739. https://doi.org/10.1111/jcpp.12823
- Fadus, M. C., Ginsburg, K. R., Sobowale, K., Halliday-Boykins, C. A., Bryant, B. E., Gray, K. M., & Squeglia, L. M. (2020). Unconscious bias and the diagnosis of disruptive behavior disorders and ADHD in African American and Hispanic youth. Academic Psychiatry, 44(1), 95–102. https://doi.org/10.1007/s40596-019-01127-6
- Patterson, G. R. (1982). A social learning approach: Vol. 3. Coercive family process. Castalia.
- Hoover, D. W., & Milich, R. (1994). Effects of sugar ingestion expectancies on mother–child interactions. Journal of Abnormal Child Psychology, 22(4), 501–515. https://doi.org/10.1007/BF02168088
- Booker, J. A., Capriola-Hall, N. N., Greene, R. W., & Ollendick, T. H. (2020). The parent–child relationship and posttreatment child outcomes across two treatments for oppositional defiant disorder. Journal of Clinical Child & Adolescent Psychology, 49(3), 405–419. https://doi.org/10.1080/15374416.2018.1555761
- Furlong, M., McGilloway, S., Bywater, T., Hutchings, J., Smith, S. M., & Donnelly, M. (2012). Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12 years. Cochrane Database of Systematic Reviews, 2012(2), Article CD008225. https://doi.org/10.1002/14651858.CD008225.pub2
- Selph, S. S., Brodt, E., Dana, T., Skelly, A. C., Atchison, C., Fu, R., Yu, Y., Riopelle, D., Morris, S. S., Schmidt, L., Ahmed, A., Williams, L., & Freeman, K. A. (2026). Psychosocial interventions for disruptive behavior in children and adolescents: A meta-analysis. Pediatrics, 157(2), Article e2025072476. https://doi.org/10.1542/peds.2025-072476
- Kaminski, J. W., Valle, L. A., Filene, J. H., & Boyle, C. L. (2008). A meta-analytic review of components associated with parent training program effectiveness. Journal of Abnormal Child Psychology, 36(4), 567–589. https://doi.org/10.1007/s10802-007-9201-9
- Kaminski, J. W., & Claussen, A. H. (2017). Evidence base update for psychosocial treatments for disruptive behaviors in children. Journal of Clinical Child & Adolescent Psychology, 46(4), 477–499. https://doi.org/10.1080/15374416.2017.1310044
- National Institute for Health and Care Excellence. (2013, updated 2017). Antisocial behaviour and conduct disorders in children and young people: Recognition and management (Clinical guideline CG158). https://www.nice.org.uk/guidance/cg158
- Steiner, H., & Remsing, L. (2007). Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 46(1), 126–141. https://doi.org/10.1097/01.chi.0000246060.62706.af
- Greene, R. W. (1998). The explosive child: A new approach for understanding and parenting easily frustrated, “chronically inflexible” children. HarperCollins.
- Ollendick, T. H., Greene, R. W., Austin, K. E., Fraire, M. G., Halldorsdottir, T., Allen, K. B., Jarrett, M. A., Lewis, K. M., Whitmore Smith, M., Cunningham, N. R., Noguchi, R. J. P., Canavera, K., & Wolff, J. C. (2016). Parent management training and Collaborative & Proactive Solutions: A randomized control trial for oppositional youth. Journal of Clinical Child & Adolescent Psychology, 45(5), 591–604. https://doi.org/10.1080/15374416.2015.1004681
- Murrihy, R. C., Drysdale, S. A. O., Dedousis-Wallace, A., Rémond, L., McAloon, J., Ellis, D. M., Halldorsdottir, T., Greene, R. W., & Ollendick, T. H. (2023). Community-delivered Collaborative and Proactive Solutions and parent management training for oppositional youth: A randomized trial. Behavior Therapy, 54(2), 400–417. https://doi.org/10.1016/j.beth.2022.10.005
- Pringsheim, T., Hirsch, L., Gardner, D., & Gorman, D. A. (2015). The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: A systematic review and meta-analysis. Part 1: Psychostimulants, alpha-2 agonists, and atomoxetine. Canadian Journal of Psychiatry, 60(2), 42–51. https://doi.org/10.1177/070674371506000202
- Loy, J. H., Merry, S. N., Hetrick, S. E., & Stasiak, K. (2017). Atypical antipsychotics for disruptive behaviour disorders in children and youths. Cochrane Database of Systematic Reviews, 2017(8), Article CD008559. https://doi.org/10.1002/14651858.CD008559.pub3
- Selph, S. S., Skelly, A. C., Dana, T., Brodt, E., Atchison, C., Riopelle, D., Stabler-Morris, S., Schmidt, L., Ahmed, A., Williams, L., Fu, R., Yu, Y., & Freeman, K. (2025). Psychosocial and pharmacologic interventions for disruptive behavior in children and adolescents: A systematic review (AHRQ Publication No. 25-EHC024). Agency for Healthcare Research and Quality. https://doi.org/10.23970/ahrqepcsrdisruptive
- Mitchell, S. (2026). Treatment of disruptive mood dysregulation disorder with autism spectrum disorder and attention-deficit/hyperactivity disorder. Mental Health Clinician, 16(1), 1–6. https://doi.org/10.9740/mhc.2026.02.001
- Verdoux, H. (2025). Antipsychotic off-label use in the 21st century: An enduring public health concern. Dialogues in Clinical Neuroscience, 27(1), 1–12. https://doi.org/10.1080/19585969.2025.2449833
- Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., Dittmann, R. W., Simonoff, E., Zuddas, A., Banaschewski, T., Buitelaar, J., Coghill, D., Hollis, C., Konofal, E., Lecendreux, M., . . . Sergeant, J. (2013). Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry, 170(3), 275–289. https://doi.org/10.1176/appi.ajp.2012.12070991
- Gajos, J. M., & Beaver, K. M. (2016). The effect of omega-3 fatty acids on aggression: A meta-analysis. Neuroscience & Biobehavioral Reviews, 69, 147–158. https://doi.org/10.1016/j.neubiorev.2016.07.017
- Raine, A., Portnoy, J., Liu, J., Mahoomed, T., & Hibbeln, J. R. (2015). Reduction in behavior problems with omega-3 supplementation in children aged 8–16 years: A randomized, double-blind, placebo-controlled, stratified, parallel-group trial. Journal of Child Psychology and Psychiatry, 56(5), 509–520. https://doi.org/10.1111/jcpp.12314
- Stevens, L., Zhang, W., Peck, L., Kuczek, T., Grevstad, N., Mahon, A., Zentall, S. S., Arnold, L. E., & Burgess, J. R. (2003). EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors. Lipids, 38(10), 1007–1021. https://doi.org/10.1007/s11745-006-1155-0
- Young, A. S., Arnold, L. E., Wolfson, H. L., & Fristad, M. A. (2017). Psychoeducational psychotherapy and omega-3 supplementation improve co-occurring behavioral problems in youth with depression: Results from a pilot RCT. Journal of Abnormal Child Psychology, 45(5), 1025–1037. https://doi.org/10.1007/s10802-016-0203-3
- Duke, A. A., Bègue, L., Bell, R., & Eisenlohr-Moul, T. (2013). Revisiting the serotonin–aggression relation in humans: A meta-analysis. Psychological Bulletin, 139(5), 1148–1172. https://doi.org/10.1037/a0031544
- Rucklidge, J. J., Eggleston, M. J. F., Johnstone, J. M., Darling, K., & Frampton, C. M. (2018). Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: A fully blinded, randomized, placebo-controlled trial. Journal of Child Psychology and Psychiatry, 59(3), 232–246. https://doi.org/10.1111/jcpp.12817
- Johnstone, J. M., Hatsu, I., Tost, G., Srikanth, P., Eiterman, L. P., Bruton, A. M., Ast, H. K., Robinette, L. M., Stern, M. M., Millington, E. G., Gracious, B. L., Hughes, A. J., Leung, B. M. Y., & Arnold, L. E. (2022). Micronutrients for attention-deficit/hyperactivity disorder in youths: A placebo-controlled randomized clinical trial. Journal of the American Academy of Child & Adolescent Psychiatry, 61(5), 647–661. https://doi.org/10.1016/j.jaac.2021.07.005
- Gesch, C. B., Hammond, S. M., Hampson, S. E., Eves, A., & Crowder, M. J. (2002). Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners: Randomised, placebo-controlled trial. British Journal of Psychiatry, 181(1), 22–28. https://doi.org/10.1192/bjp.181.1.22
- Zaalberg, A., Nijman, H., Bulten, E., Stroosma, L., & van der Staak, C. (2010). Effects of nutritional supplements on aggression, rule-breaking, and psychopathology among young adult prisoners. Aggressive Behavior, 36(2), 117–126. https://doi.org/10.1002/ab.20335
- Tammam, J. D., Steinsaltz, D., Bester, D. W., Semb-Andenaes, T., & Stein, J. F. (2016). A randomised double-blind placebo-controlled trial investigating the behavioural effects of vitamin, mineral and n-3 fatty acid supplementation in typically developing adolescent schoolchildren. British Journal of Nutrition, 115(2), 361–373. https://doi.org/10.1017/S0007114515004390
- Sandboge, S., Räikkönen, K., Lahti-Pulkkinen, M., Hauta-Alus, H., Holmlund-Suila, E., Girchenko, P., Kajantie, E., Mäkitie, O., Andersson, S., & Heinonen, K. (2023). Effect of vitamin D3 supplementation in the first 2 years of life on psychiatric symptoms at ages 6 to 8 years: A randomized clinical trial. JAMA Network Open, 6(5), Article e2314319. https://doi.org/10.1001/jamanetworkopen.2023.14319
- Arnold, L. E., Disilvestro, R. A., Bozzolo, D., Bozzolo, H., Crowl, L., Fernandez, S., Ramadan, Y., Thompson, S., Mo, X., Abdel-Rasoul, M., & Joseph, E. (2011). Zinc for attention-deficit/hyperactivity disorder: Placebo-controlled double-blind pilot trial alone and combined with amphetamine. Journal of Child and Adolescent Psychopharmacology, 21(1), 1–19. https://doi.org/10.1089/cap.2010.0073
- Cortese, S., Angriman, M., Lecendreux, M., & Konofal, E. (2012). Iron and attention deficit/hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature. Expert Review of Neurotherapeutics, 12(10), 1227–1240. https://doi.org/10.1586/ern.12.116
- Hemamy, M., Heidari-Beni, M., Askari, G., Karahmadi, M., & Maracy, M. (2020). Effect of vitamin D and magnesium supplementation on behavior problems in children with attention-deficit hyperactivity disorder. International Journal of Preventive Medicine, 11(1), Article 4. https://doi.org/10.4103/ijpvm.IJPVM_546_17
- Lyon, M. R., Kapoor, M. P., & Juneja, L. R. (2011). The effects of L-theanine (Suntheanine) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): A randomized, double-blind, placebo-controlled clinical trial. Alternative Medicine Review, 16(4), 348–354. PubMed ID 22214254. https://pubmed.ncbi.nlm.nih.gov/22214254/
- Amsterdam, J. D., Li, Y., Soeller, I., Rockwell, K., Mao, J. J., & Shults, J. (2009). A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology, 29(4), 378–382. https://doi.org/10.1097/JCP.0b013e3181ac935c
- Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J. A., & Colzato, L. S. (2015). A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, Behavior, and Immunity, 48, 258–264. https://doi.org/10.1016/j.bbi.2015.04.003
- Schmidt, K., Cowen, P. J., Harmer, C. J., Tzortzis, G., Errington, S., & Burnet, P. W. J. (2015). Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology, 232(10), 1793–1801. https://doi.org/10.1007/s00213-014-3810-0
- U.S. Food and Drug Administration. (2024, October 1). Dietary supplements. https://www.fda.gov/food/dietary-supplements
- Pelsser, L. M., Frankena, K., Toorman, J., Savelkoul, H. F., Dubois, A. E., Pereira, R. R., Haagen, T. A., Rommelse, N. N., & Buitelaar, J. K. (2011). Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): A randomised controlled trial. The Lancet, 377(9764), 494–503. https://doi.org/10.1016/S0140-6736(10)62227-1
- Nigg, J. T., Lewis, K., Edinger, T., & Falk, M. (2012). Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. Journal of the American Academy of Child & Adolescent Psychiatry, 51(1), 86–97.e8. https://doi.org/10.1016/j.jaac.2011.10.015
- Wolraich, M. L., Wilson, D. B., & White, J. W. (1995). The effect of sugar on behavior or cognition in children: A meta-analysis. JAMA, 274(20), 1617–1621. https://doi.org/10.1001/jama.1995.03530200053037
- Gregory, A. M., & Sadeh, A. (2012). Sleep, emotional and behavioral difficulties in children and adolescents. Sleep Medicine Reviews, 16(2), 129–136. https://doi.org/10.1016/j.smrv.2011.03.007
- Lelak, K., Vohra, V., Neuman, M. I., Toce, M. S., & Sethuraman, U. (2022). Pediatric melatonin ingestions: United States, 2012–2021. MMWR Morbidity and Mortality Weekly Report, 71(22), 725–729. https://doi.org/10.15585/mmwr.mm7122a1
- Spruit, A., Assink, M., van Vugt, E., van der Put, C., & Stams, G. J. (2016). The effects of physical activity interventions on psychosocial outcomes in adolescents: A meta-analytic review. Clinical Psychology Review, 45, 56–71. https://doi.org/10.1016/j.cpr.2016.03.006


















0 Comments